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Retinoic Acid Receptor  Controls Development of
Striatonigral Projection Neurons through FGF-Dependent
and Meis1-Dependent Mechanisms
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The mammalian striatum controls sensorimotor and psychoaffective functions through coordinated activities of its two striatonigral and
striatopallidal output pathways. Here we show that retinoic acid receptor  (RAR) controls development of a subpopulation of GABAergic,
Gad65-positive striatonigral projectionneurons. InRarb/ knock-outmice, concomitant reduction ofGad65, dopamine receptorD1 (Drd1),
and substance P expression at different phases of prenatal development was associatedwith reduced number ofDrd1-positive cells at birth, in
contrast to normal numbers of striatopallidal projection neurons expressing dopamine receptor D2. Fate mapping using BrdU pulse-chase
experiments revealed that such deficitsmay originate from compromised proliferation of late-born striosomal neurons and lead to decreased
numberofDrd1-positive cells retainingBrdUinpostnatalday (P)0Rarb/ striatum.ReducedexpressionofFgf3 in the subventricular zoneof
the lateral ganglionic eminence (LGE) at embryonic day 13.5 may underlie such deficits by inducing premature differentiation of neuronal
progenitors,asillustratedbyreducedexpressionoftheproneuralgeneAscl1(Mash1)andincreasedexpressionofMeis1,amarkerofpostmitotic
LGEneurons. In agreementwith a critical role of FGF3 in this control, reduced number of Ascl1-expressing neural progenitors, and a concom-
itant increase of Meis1-expressing cells, were observed in primary cell cultures of Rarb/ LGE. This defect was normalized by addition of
fibroblastgrowthfactor(FGF).SuchdatapointtoroleofMeis1instriataldevelopment,alsosupportedbyreducedneuronaldifferentiationinthe
LGE ofMeis1/ embryos. Our data unveil a novelmechanism of development of striatonigral projection neurons involving retinoic acid and
FGF, two signals required for positioning the boundaries ofMeis1-expressing cells.
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Introduction
The striatum, the primary input structure of basal ganglia, de-
rives from the embryonic lateral ganglionic eminence (LGE;
Molero et al., 2009). Medium spiny projection neurons (MSNs)
constitute a vast majority (90–95%) of striatal neurons and are
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Significance Statement
Weprovide the first evidence that retinoic acid signaling controls development of striatonigral projection neurons, which consti-
tute one of the twomajor output pathways of the striatum.Our data point to retinoic acid receptor (RAR) as novel determinant
of striatonigral pathway development, and indicate that such activities of RAR are mediated by abnormal FGF3 and Meis1
signaling, but do not involve Isl1, Ctip2, or Ebf1, the only factors known so far to control development of these neurons. Further-
more, present data support possibility that lateral ganglionic eminence development is controlled by gradients of fibroblast
growth factor and RA signaling.
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formed in the proliferative zones of the LGE including ventricu-
lar zone (VZ) and subventricular zone (SVZ).Newly formed pro-
genitor cells migrate radially to the adjacent mantle zone (MZ),
where they segregate into two discrete compartments: the strio-
somes (also called patches) and surrounding matrix. In mice,
formation of striosomes between embryonic day (E) 11 and E14
precedes formation of matrix at E16–P0 and is associated with
different afferent connections of these domains (van der Kooy
and Fishell, 1987). Although MSNs are intermixed in both com-
partments, they can be divided according to targets of their ax-
onal projections into striatonigral and striatopallidal projection
neurons, which form the main striatal output pathway and pro-
vide, respectively, direct or indirect connections with substantia
nigra. Whereas both types of projection neurons are GABAergic
and express two forms of glutamic acid decarboxylases (Gad67
and/or Gad65), they also display a number of molecular differ-
ences, including expression of dopamineD1 receptor (Drd1) and
substance P (SP) in striatonigral neurons and dopamine D2 re-
ceptor (Drd2), proenkephaline (Penk), or adenosine A2A recep-
tor (Adora2a) in striatopallidal neurons. Coordinated activities
of these pathways are important for control of motor, affective,
and cognitive functions, which are underlined by a wide range of
behavioral abnormalities associated with their imbalanced activ-
ity in degenerative diseases, such as Huntington disease and Par-
kinson disease, in drug abuse, or in depression (Crittenden and
Graybiel, 2011). Despite a vast knowledge about molecular and
functional differences between striatonigral and striatopallidal
pathways, developmental mechanisms underlying generation of
these two types of projection neurons are only beginning to be
elucidated. Recent reports have focused on Isl1 (Ehrman et al.,
2013; Lu et al., 2014), Ctip2 (Arlotta et al., 2008), or Ebf1 (Lobo et
al., 2008), which through different mechanisms preferentially
control development of the striatonigral pathway. In particular,
Isl1 was shown to promote development, but also maintenance,
of striatonigral neurons (Lu et al., 2014).Mechanisms coordinat-
ing expression and activities of these different transcription fac-
tors in LGE are not known, although the two potential candidates
could include fibroblast growth factors (FGFs) and retinoic acid
(RA), both acting as diffusible molecules critical for brain mor-
phogenesis, cell-type specification, and differentiation. FGFs are
known to control expansion of neural progenitors in different
brain regions, including the telencephalon (Diez del Corral et al.,
2003; Storm et al., 2003, 2006; Gutin et al., 2006; Theil et al.,
2008), and signaling through FGF receptors 1–3 has been pro-
posed to mediate organizer activity in developing LGE (Paek et
al., 2009). In agreement with the high differentiating potential of
RA, its reduced availability in LGE of Raldh3/ mice signifi-
cantly decreased differentiation of GABAergic projection neu-
rons (Chatzi et al., 2011). The RA signal could be mediated
through two RA receptors (RARs), RAR, which is expressed in
the SVZ region, or RAR, which is expressed in the SVZ region as
well as at high levels in the MZ (Ruberte et al., 1993). RAR was
shown to control development of striosomal compartments
(Liao et al., 2008), but its contribution to development of striatal
projection neurons has not been assessed. Here we show that
genetic ablation of RAR leads to selective reduction of striatoni-
gral projection neurons. Premature neuronal differentiation re-
flected by ectopic expression of the postmitotic marker Meis1 in
VZ and SVZ neurons, at the expense of progenitor cells express-
ing the proneural geneAscl1 (Mash1), may directly underlie such
deficits and result from reduced FGF3 signaling, one of the direct
transcriptional targets of RA signaling.
Materials andMethods
Animals and tissue preparation.Nullmutantmice and embryos for RAR
(Rarb/) and null mutant embryos for Meis1 (Meis1/), and their
respective wild-type (WT) littermate controls, were generated on a
mixed genetic background (129/SvEmj; C57BL/6J) from heterozygous
crosses as previously described (Ghyselinck et al., 1997; Azcoitia et al.,
2005). Meanwhile, WT and Rarb/ embryos used for primary cultures
of LGE cells were generated from homozygous crosses (WT WT and
Rarb/Rarb/) ofmice with the same genetic background. The day
of the vaginal plug following overnight mating was considered as 0.5 d
postcoitum (E0.5). Genotypes of all animals were determined using ap-
propriate PCRs (genotyping protocols available upon request).
For immunohistochemical and in situ hybridization (ISH) analyses,
embryonic or adult brains were dissected on ice, fixed with 4% parafor-
maldehyde (PFA) in phosphate-buffered saline (PBS), cryoprotected in
20% sucrose solution in PBS for 24 h, embedded in ShandonCryomatrix
(Thermo Scientific), frozen, and stored at80°C. Coronal cryosections
(14mthick) were collected onto Superfrost plus slides (Menzel-Glaser)
and stored at80°C until analysis.
Short-term and long-termBrdU tracing.Pregnant femaleswere injected
intraperitoneallywith 100mg/kgBrdU (Sigma-Aldrich) at E13 and killed
at different time points to conduct the necessary experiment. Quantifi-
cation of the population of proliferating cells was performed as described
previously (Martynoga et al., 2005; Tucker et al., 2010). Briefly, for birth-
dating analyses, pregnant females were injected with BrdU at E13.0 and
the embryos or brains were collected at E13.5, E18.5, or at birth (P0), and
processed for immunohistochemical analyses.
Primary cell culture. To obtain necessary material for primary LGE
cultures and to ensure consistant experimental conditions, we pooled
LGEs from 4–5 embryos (E13.5) of a given genotype to constitute one
experimental sample, and 4 samples were analyzed for each genotype
in each experimental condition. Dissected LGEs were incubated in non-
enzymatic dissociation buffer (Invitrogen, 13150-016) at 37°C for 15min
and subsequently triturated using fire-polished Pasteur glass pipettes to
obtain single-cell suspension. For cell-pair assays, cells were plated at a
concentration of 60–80  103 cells/ml on 12 mm glass coverslips pre-
coated with laminin (BD Bioscience, 354232) and cultured for 24 h in a
humidified incubator at 37°C with 5% CO2. Cells were cultured in neu-
robasal medium (Invitrogen, 21103-049) with N2 supplement (Invitro-
gen, 17502-048) or in medium enriched with trophic factors containing
B27 (Invitrogen, 12587-010) and 40 ng/ml FGF2 (human; Peprotech).
Immunohistochemistry and immunocytochemistry. Slides with fixed tis-
sue sections or cultured cells were blocked with normal goat serum or
fetal calf serum and incubated with the following primary antibodies: rat
BrdU (1:10; Serotec, OBT0030S); rabbit Ki67 (1:200; Novocastra, NCL-
Ki67p); rabbit Meis1 (1:400; Azcoitia et al., 2005); mouse Ascl1/Mash1
(1:200; BD PharMingen, 556604); rabbit Ascl1/Mash1 (1:10,000; a gift
from Jane E. Johnson, University of Texas Southwestern Medical Cen-
ter); mouse Isl1/2 (1:100; 39.4D5 from Hybridoma Bank); rabbit Foxp1
(1:500; Abcam, AB16645); activated caspase 3 (1:200; BioVision, 3015-
100). Heat-induced antigen retrieval was used for immunodetection of
BrdU. Primary antibodies were visualized using secondary antibodies
from donkey conjugated with Alexa 488 or Alexa 555 (1:1000; Fisher
Scientific), whereas cell nuclei were identified using DAPI (1:2000).
ISH and quantitative real-time PCR. Chromogenic ISHs were per-
formed with digoxigenin-labeled riboprobes targeting gene-specific re-
gions described previously: Rara and Rarb (Dolle´ et al., 1990); Gad65
(Erlander et al., 1991), Ascl1 (Mash1, full-length cDNA), Ikzf1 (full-
length cDNA),Meis1 (nucleotides 415–475 region of cDNA);Dlk1 (full-
length cDNA, gift from J. Lewis); Fgf3 (532 bp 3 cDNA region; gift from
D. Wilkinson); Foxp1 (nucleotides 350–700 region of cDNA); Isl1 (nu-
cleotides 380–513 region of cDNA), Ctip2 (full-length cDNA), Pdyn
(1.7kb 3 region of cDNA),Chmr4 (full-length cDNA). The expression of
each gene was analyzed in n 4–6 WT and n 4–6 Rarb/ biologi-
cally independent embryos or newborn mice (as specified in the text)
using several sections of the striatum at corresponding anteroposterior
positions and separated by 70 m. Hybridization conditions were as
described previously (Krezel et al., 1998). Detailed protocols for probe
14468 • J. Neurosci., October 28, 2015 • 35(43):14467–14475 Rataj-Baniowska et al. • RAR in Development of Striatonigral Projection Neurons
synthesis and ISH are available on the website http://www.empress.har.
mrc.ac.uk/browser: gene expression section. For BrdU detection after ISH,
antigen retrieval was performed before ISH, whereas immunofluorescent
detection of BrdU was performed, using anti-BrdU monoclonal antibody
followed by Alexa 488 secondary antibody, simultaneously with immuno-
detection of dig-labeledDrd1orDrd2 antisense probes. For fluorescent ISH,
we used frozen brain section from P0 pups that were deep anesthetized and
perfused with 4% PFA. Detection of probes was done using peroxidase-
conjugated sheep anti-dig antibody (reference #11207733910, Roche) and
revealed with TSA Plus Cyanine 3 System (PerkinElmer). Quantitative real-
time PCR (qRT-PCR) was performed on dissected E13.5, E16.5, and E18.5
LGE samples (n 5WT and 5 Rarb/ for each stage) and normalized for
expression of a housekeeping gene 36B4 as previously described (Krzyzo-
siak et al., 2010). PCRs were performed in duplicate or triplicate with
good reproducibility rate (error, 10%). Forward and reverse primers
used for these analyses were respectively as follows: Adora2a: CAGAG
TTCCATCTTCAGCCTC, CACCCAGCAAATCGCAATG; Ascl1: TTCT
CCGGTCTCGTCCTACTC, CCAGTTGGTAAAGTCCAGCAG; Ctip2: T
GCGTCTGTACAGCGTGAC, ACTTCGCAGACACAGGTTAGG; Dlk1:GA
AAGGACTGCCAGCACAAG, CACAGAAGTTGCCTGAGAAGC; Drd1:
AAGATGCCGAGGATGACAAC, CCCTCTCCAAAGCTGAGATG;Drd2:
TCGCCATTGTCTGGGTCCTG, TGCCCTTGAGTGGTGTCTTC; Ebf1: AG
GTACGCCCTCTTATCTGG, GACCAGCATGGTACCGAATA; Gad65:
GGGATGTCAACTACGCGTTTC,GAGTGGGCCTTTCTCCATCA;Gad67:
GGGTTCCAGATAGCCCTGAGCGA, TGGCCTTGTCCCCTTGAGG
CT; Fgf3: GATTACTGCGGTGGAAGTGG, GCGTTGTAGTGATC
CGAAGC; Isl1: CAGCAACCCAACGACAAAAC, GTCACTCAGTACTT
TCCAGGG; Meis1: GGTGTTCGCCAAACAGATT, GGTGGCAGAAATT
GTCACAT; Penk, AAAATCTGGGAGACCTGCAA, TCTTCTGGCTCCA
TGGGATA;Raldh3: AGTGTGGAGTTCGCCAAGAAGAGG, AGACCG
TGGGTTTGATGAACAGCC; SP (Tac1): AGGCTCTTTATGGACAT
GGC, TCTTTCGTAGTTCTGCATCGC.
Cell counts and statistical analyses. All analyses and imaging were per-
formed using LeicaM420 or DMLB/DM4000Bmicroscopes equipped with
Photometrics digital cameras and the CoolSnap imaging software (Roger
Scientific). The cells were counted manually using ImageJ software (Ras-
band, http://rsb.info.nih.gov/ij/) and automatically using a software devel-
oped in the laboratory (M. Baniowski, unpublished). Both methods gave
similar results. For the primary cell cultures,DAPI-positive cells were scored
toquantifyglobal cellnumber.AdjacentDAPI-positivecellswereconsidered
as divided cell pairs. BrdU-positive, Drd1-positive, or Drd2-positive cells
were quantified in both hemispheres from LGE and striatum using 3–4
sections separated by 70m for E13.5 or by 100m for E18.5 embryos and
P0 mice (only the latter were used for Drd1 and Drd2 cell counts). Two
independent experimenters counted cells from the same areas.
Statistical analyses were performed using Student’s t test to compare
WT and Rarb/ samples (e.g., on qRT-PCR data). For analyses of FGF
effects in WT and Rarb/ primary LGE cell cultures, two-way ANOVA
was usedwith genotype and treatment as independent variables. ANOVA
analyses were followed by Student’s t test post hoc comparisons (StatView
software).
Results
Proliferation deficits result in reduced number of
striatonigral projection neurons in the developing striatum of
perinatal Rarb/mice
Consistent with a previous report (Liao et al., 2008), we observed
that a single injection of BrdUduring the early wave of neurogen-
esis at E13.0 marked fewer cells in the SVZ of the Rarb/ LGE
than in the SVZ of WT LGE when assayed 2 h after injection
(Rarb/ attained 82 5% of WT cell counts; Fig. 1A,A), and
such difference was even stronger when counting BrdU cells in
the MZ of the Rarb/ LGE at E18.5 (61 5% of WT cells; Fig.
1B,B) or P0 (69  4% of WT cells; Fig. 1C2,D2,I). To test
whether reduced cell proliferation at E13.0 results in reduced
numbers of projection neurons, we quantified the numbers of
Drd1 and Drd2 neurons in the striatum of newborn mice
(P0) by fluorescence ISH, and determined whether they retained
BrdU injected at E13.0 (Fig. 1C1–D4). We observed a significant
(	50%) reduction ofDrd1 and BrdU double-labeled cells, which
was associated with an overall 23  8% reduction of Drd1
neurons in Rarb/ striatum (Fig. 1I), indicating a deficit in the
number of striatonigral projection neurons generated during this
period of neurogenesis. In contrast, the number ofDrd2-positive
neurons including those that accumulated BrdU injected at E13.0
was not different between WT and Rarb/ striatum (Fig. 1I).
Reduction of Drd1-positive neurons, evident also at E18.5 (Fig.
1E,E), was restricted to striosomal compartments, as prodynor-
phin, a marker of striosomal Drd1 neurons, was strongly dimin-
ished in the anterior part of Rarb/ striatum (Fig 1F,F),
whereas expression of Chrm4, a marker of matrix Drd1 neurons
was not affected (Fig 1G,G). In agreement with a previous report
(Liao et al., 2008), striosomal compartmentalization of pro-
dynorphin expression was affected mostly in anterior, but not in
posterior, striatum. Expression of Drd2 was not reduced
throughout E18.5 Rarb/ striatum (Fig. 1H,H). In concor-
dance with reduced number of striatonigral projection neurons,
levels of Drd1 and SP, an additional marker of striatonigral pro-
jection neurons, were significantly lower in Rarb/ LGE at
E18.5 as assessed by qRT-PCR (Fig. 1J). There was no effect of
RAR ablation on the expression of striatopallidal markers in-
cluding Drd2, Penk1, or Adora2a (Fig. 1I), supporting the idea
that this pathway is not affected in Rarb/ mice. Interestingly,
whereas expression of Gad67 was not affected, the expression of
Gad65, preferentially associated with functions of striatonigral
projection neurons (Laprade and Soghomonian, 1997), was de-
creased, further suggesting pathway-specific deficits (Fig. 1J).
Ectopic expression of Isl1 andMeis1 in VZ and SVZ indicates
premature differentiation of neural progenitors in the
Rarb/ LGE
To identify mechanisms underlying deficient generation of stria-
tonigral projection neurons, we analyzed the expression of Isl1,
Ctip2, and Ebf1, known to contribute to specification of these
cells. The mRNA levels and distribution of these determinants
were not affected at E13.5 with exception of a weak decrease of
Ctip2 expression (Fig. 2A–B,I). However, cells expressing high
levels of Isl1 protein were found in the SVZ (Fig. 2, compare
G1–G3 forWT,G1–G3 forRarb/) and sporadically in the VZ
of Rarb/ LGE, where their expression was restricted to Ascl1
neural progenitor cells (Fig. 2G3, arrows). Such distribution of
Isl1, normally expressed at high levels in postmitotic differentiat-
ing neurons of the MZ of the LGE, suggested that premature
differentiation of neural progenitor cells may underlie the re-
duced proliferation index we observed in the Rarb/ striatum.
To test this hypothesis, we investigated expression of Meis1, a
marker of postmitotic differentiated neurons in the striatum.Us-
ing ISH (Fig. 2C,C) and qRT-PCR (Fig. 2I), we found a signifi-
cant increase ofMeis1 expression, distributed in patchy zones of
ectopic expression in the VZ (Fig. 2C,C) in 4 of 5 analyzed em-
bryos, which was accompanied by reduction of Ascl1 expression
in Rarb/ VZ of the LGE (Fig. 2D,D,I). Consistent with Meis1
overexpression being functionally relevant, expression of Dlk1,
a direct transcriptional target of Meis1 (Argiropoulos et al.,
2008), known to promote neurogenesis of human and mouse
neural progenitors (Surmacz et al., 2012), was also increased in
Rarb/ LGE and displayed ectopic expression in the VZ region
(Fig. 2E,E,I) with high penetrance (four of five analyzed em-
bryos). Immunohistological analyses confirmed increasedMeis1
expression and revealed the presence of Meis1-positive cells in
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ectopic, patchy-like regions of the VZ of
mutant embryos illustrated in Figure 2
(compareH1–H3,H1–H3). In contrast,
Ascl1-expressing cells were significantly
reduced inRarb/VZ (72 10%ofWT;
p  0.05) and some of them also coex-
pressed Meis1.
Along with premature neuronal differ-
entiation associated with enhanced and
ectopic expression of Meis1 in the
Rarb/ striatum at E13.5, we identified by
qRT-PCR reduced expression of Foxp1
(77 6%ofWT, p 0.05) and Ikzf1 (37
15% of WT, p 0.05), distinct markers of
neuronaldifferentiation in theLGE.This re-
sult was intriguing since Foxp1 is a broad-
spectrum marker of projection neurons
(Tamura et al., 2004) and Ikzf1 preferen-
tially controlsdevelopmentof striatopallidal
projection neurons (Martín-Iba´n˜ez et al.,
2010), whereas deficit detected at E18.5 in
theRarb/LGEwas restricted to striatoni-
gral projectionneurons (Fig. 1F).We there-
fore tested the hypothesis that more severe
deficits in differentiation of projection neu-
rons or their subtypes might be present at
earlier stages of development than E18.5. In
support of increased severity of deficits, ex-
pression of Gad65 (60.9% of WT; p 
0.007) andGad67 (63.7%ofWT, p 0.05),
markers of differentiated GABAergic pro-
jection neurons, was strongly reduced at
E16.5. However, these changes reflected
compromised differentiation of striatoni-
gral projection neurons as there was re-
duced expression ofDrd1 (51%ofWT, p
0.04) and SP (33.7%ofWT, p 0.05), con-
trasting with normal expression of Drd2
(104%ofWT;ns) andPenk (100.2%ofWT;
not significant) in the E16.5 Rarb/ LGE.
In agreementwith aprevious report (Liao et
al., 2008), we did not detect any differences
in apoptosis using TUNEL inRarb/ LGE
at E13.5, E16.5, or E18.5.
Premature differentiation is associated
with reduced FGF signaling in the
Rarb/ LGE
The effect of loss of function of RAR ex-
pressed in the MZ/SVZ region of the LGE
(Liao et al., 2003) on the proliferation of
progenitor cells located in the VZ was in-
triguing. To address the mechanisms of
such long-range RAR functions, we asked
whether abnormal signaling through diffusible factors controlling
maintenance and differentiation of neural progenitors could be al-
tered in the Rarb/ LGE. We focused these analyses on RA and
FGFs acting in the SVZ and/or VZ through their respective recep-
tors,RARandFGFR1–2. Since expressionofRaldh3andRarawere
not affected (Fig. 2I),we focused further analysesonFGFs, knownas
important inhibitors of terminal differentiation, including FGF3
and FGF8 controlling early development of the LGE (Theil et al.,
2008).AtE13.5,Fgf8 transcriptsweredetectedonly in thedeveloping
septum, and were absent from the LGE (both in WT and Rarb/
mice) as determined by ISH and qRT-PCR. Expression of Fgf3 was
detected in the SVZ of theWT LGE, but was reduced in the SVZ of
Rarb/ embryos (Fig. 2F,F,I).Reduced expressionofFgf3 is likely
to be of transcriptional origin, as Fgf3 is one of the direct RA tran-
scriptional targets (Murakami et al., 1993). Compromised Fgf3 ex-
pressionmayresult in reducedglobalFGFsignaling in theSVZof the
Rarb/ LGE, since other Fgfs (FGF1, FGF2, FGF4, and FGF5) act-
ing as ligands of FGF receptors (FGFR1 and FGFR2) implicated in
Figure 1. Reduced proliferation of striatonigral neurons in Rarb/ LGE. A–D4, Coronal brain sections of the LGE or
striatum (drawings, top left) were analyzed at E13.5 (A and A), E18.5 (B and B), and P0 (C1–C4 and D1–D4 ), following
a maternal BrdU injection at E13 (BrdU, green; DAPI, blue) in WT (A, B, C1–C4, and D1–D4 ) and Rarb/ mice (A and
B). Drd1-expressing cells (C1–C4, red) and Drd2-expressing cells (D1–D4, red) were identified by fluorescent ISH and
their overlap with BrdU immunolabeling is illustrated for WT dorsal striatum at P0 (C2–C4 and D2–D4 ). C4, D4, I, Details
of colabeled cells are indicated by arrows at higher magnification for Drd1 (C4 ) and Drd2 (D4 ), whereas respective cell
counts are shown in I. E–H, Expression of Drd1 (E and E), Pdyn (F and F), Chmr4 (G and G) and Drd2 (H and H) were
tested at E18.5 and are shown for WT (E,F,G,H ) and Rarb/ (E, F, G, and H) striatum. J, mRNA expression of
striatonigral (Drd1, SP) and striatopallidal markers (Drd2, Penk, Adora2a) was quantified by qRT-PCR in E18.5 LGE prepa-
rations. Scale bars: A, 500m; B, 200m; C1, 50m; E, 200m. *p 0.05, **p 0.01, ***p 0.001 compared with
WT group (Student’s t test). Error bars represent SEM.
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LGEdevelopment (Gutin et al., 2006)were not detected in theE13.5
LGE as determined by qRT-PCR and ISH. A consequence of FGF
deficiencymaybe increaseddifferentiationofneural progenitor cells
in the VZ and SVZ.
To better understand the dependence among FGF,Meis1, and
Ascl1 signaling in regulation of neuronal differentiation, we per-
formed a series of ex vivo analyses in primary LGE cell cultures,
using molecular markers of neuronal differentiation combined
with cell-pair analyses (Fig. 3A) as described previously (Shen et
al., 2004; Tucker et al., 2010). Similarly to in vivo conditions,
Figure 2. RAR ablation selectively increases differentiation markers at the expense of
determinants of neural progenitors in the E13.5 LGE. A–F, ISH analyses were performed with
various genemarkers (as detailed on left side of panels), and are illustrated on coronal sections
4
of the anterior region of the LGE. Black arrows indicate ectopic expression domains. G1–G3,
Immunofluorescence detection of Isl1 (green) and Ascl1 (red) is shown on coronal sections
throughout VZ and SVZ regions (dotted line) of the anterior LGE of WT (G1, G2, and G3) and
Rarb/ (G1, G2, and G3) embryos. Cells coexpressing both markers are indicated by
arrows. H1–H3, Immunofluorescence detection of Ascl1 (green) and Meis1 (red) is shown in
the anterior LGE ofWT (H1,H2, andH3) and Rarb/ (H1,H2, andH3) embryos. I, mRNA
expressionof selecteddevelopmentalmarkers inWTandRarb/ E13.5 LGEwas standardized
with respect to 36B4 housekeeping gene and shown as percentage of WT expression levels.
Scale bars: A, 500m; G1, 50m. *p 0.05, **p 0.01, ***p 0.001 compared withWT
group (Student’s t test). Error bars represent SEM.
Figure 3. Cell-pair analysis of progenitor cells in Rarb/ LGE primary cell cultures. A,
Examples of Meis1 and Ascl1 detection in cell pairs from LGE primary cell cultures are shown,
illustrating symmetric (top row: Meis1/Ascl1; second row: Meis1/Ascl1), and asym-
metric (bottom rows) distributions of molecular determinants. B, C, The proliferative status of
WTversusRarb/LGE cellswas investigatedby scoringKi67-positive cells, andnumberof cell
pairs (both expressed as percentage of total DAPI cells). D–F, Overall numbers of Meis1,
Ascl1, and Foxp1 cells (regardless of cell pairs)were also scored after culture in neurobasal
(FGF) and in trophic (FGF) conditions (percentages ofDAPI-labeled cells).G, Distributionof
cell pairs reflecting symmetric differentiating division (M/M:Meis1/Ascl1 cell pairs;A, top
row), symmetric “neurogenic” division (A/A: Ascl1/Ascl1 cell pairs; A, second row), and
asymmetric division (A/M: Meis1/Ascl1 cell present in one daughter cell; A, two bottom
rows). ***p 0.001 compared with WT or as indicated on the graph (Student’s t test). Error
bars represent SEM.
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proliferative deficits were reproduced in a 24 h cell culture of
dissociated LGE cells from E13.5 Rarb/ embryos seeded at
clonal density. Indeed, the percentage of proliferating cells iden-
tified by Ki67 immunolabeling was reduced by 23% in cultures
established from Rarb/ LGE, compared with WT LGE (Fig.
3B). Such deficits were further confirmed by a 22% reduction in
the overall numbers of cell pairs inRarb/ cultures, presumably
corresponding to cells that divided after plating in vitro (Fig. 3C).
Importantly, the percentage of cells immunolabeled for Meis1
was significantly increased, whereas the percentage of cells ex-
pressing Ascl1 (Mash1) was significantly decreased in Rarb/
cultures (Fig. 3D,E, FGF histogram), further supporting
the possibility of premature differentiation in the E13.5
Rarb/ LGE. In contrast to increased Meis1, the number of
Foxp1-positive cells was reduced in Rarb/ LGE cultures, thus
reproducing reduced Foxp1 expression observed by qRT-PCR in
Rarb/ LGE (Fig. 3F). In presence of FGF, this difference was
normalizedmainly through decreased number of Foxp1-positive
cells in WT but not in Rarb/ LGE cultures.
To assess whether altered neuronal differentiation inRarb/
LGE cultures involves cell-extrinsic factors, such as deficient
trophic milieu due to reduced Fgf3 expression, we cultured dis-
sociated LGEs from E13.5 embryos in B27-supplemented me-
dium in the presence of FGF2 (bFGF), an easily accessible isotype
of FGF, but with similar activity to FGF3. We found that FGF2
treatment normalized the imbalance between Meis1-expressing
and Ascl1-expressing cells, as this treatment significantly redu-
ced the number of Meis1-expressing cells (Fig. 3D, compare
FGF, FGF histograms), while increasing the Ascl1-positive
cells (Fig. 3E, compare FGF, FGF histograms), in the
Rarb/ samples.
Cell-pair analyses give an approximate overview of the per-
centage of cells undergoing (or which underwent) symmetric
versus asymmetric divisions (Shen et al., 2004; Tucker et al.,
2010). We studied the expression of Ascl1 as neurogenic marker
and Meis1 as marker of differentiating cells in presumed daugh-
ter cells, as judged by proximity (Fig. 3A, example of asymmetric
division). By seeding dissociated LGE cells at low, clonal density
we could easily identify pairs expressingMeis1 (but not Ascl1) in
both daughter cells in WT and Rarb/ cultures maintained in
N2 neurobasal medium. However, the percentage of such pairs
was	30% higher in Rarb/ cultures (28 4% of all cell pairs
for WT and 50  5% for Rarb/, p  0.01), reflecting an in-
creased number of symmetric differentiating divisions (Fig. 3G).
In contrast, the percentage of cell pairs expressing Ascl1 in both
daughter cells and presumably corresponding to cells that under-
went symmetric “neurogenic” division (i.e., which were commit-
ted to neurogenic fate but retained a progenitor/proliferative
capacity) was significantly reduced inRarb/ cultures (37 3%
inWT, 20 4% in Rarb/; p 0.01). Importantly, addition of
FGF increased the percentage of Ascl1/Ascl1 cell pairs in
Rarb/ cultures, leading to a normalization of the deficit (28
4% inWT, 28 3% inRarb/; not significant), with a concom-
itant reduction of Meis1/Meis1 cell pairs in both WT and
Rarb/ cultures, although the percentage of these cell pairs still
remained higher in Rarb/ samples (22 4% inWT, 34 4%
in Rarb/; p  0.01). Interestingly, cell pairs with asymmetric
expression of Ascl1 (i.e., in only one of the presumed daughter
cells) were not affected by genotype in cultures in neurobasal
medium (35 3% inWT, 39 3% in Rarb/; not significant),
whereas addition of FGF increased the percentage of these cell
pairs in WT cultures, but not in Rarb/ cultures (51  3% in
WT, 37 4% in Rarb/; genotype FGF treatment; F(1,12)
7.8; p 0.05). Thus, an FGF-induced shift promoting symmetric
neurogenic divisions (Ascl1/Ascl1) at the expense of differ-
entiating (Meis1/Meis) cell divisions could possibly explain
FGF effects on the global size of Ascl1-expressing and Meis1-
expressing cell populations in Rarb/ LGE cultures.
Analysis ofMeis1/ embryos supports a role for Meis1 in
neuronal differentiation in the developing striatum
The above data indicate that a gain of Meis1 function associated
with compromised RAR signaling would lead to accelerated
neurogenesis in the developing LGE. To further investigate
whether Meis1 is required for neuronal differentiation in the
LGE, we analyzedMeis1/mutant mice (Azcoitia et al., 2005).
Several molecular alterations were detected in the developing
LGE ofMeis1/ embryos, which may indicate an impaired po-
tential for terminal differentiation. Specifically, expression of
Dlk1, a transcriptional target of Meis1 and promoter of neuronal
differentiation, was strongly decreased throughout the SVZof the
LGE at E13.5 (Fig. 4A,A). Furthermore, expression of Rarb or
Ikzf1, used here as markers of differentiating neurons, were also
significantly decreased in the Meis1/ LGE (Fig. 4B–C). In
contrast, expression of Isl1 and Ctip2, implicated in specification
of striatonigral neurons, were less affected in the Meis1/ LGE
(Fig. 4D–E).
Discussion
RA is an important modulator of striatal development and con-
trols formation of striosomal compartments (Liao et al., 2008)
and differentiation of medium spiny neurons (Chatzi et al.,
2011). However, it is not clear how such modulations relate to
development of striatonigral and striatopallidal output pathways.
Here we demonstrate that RAR is implicated in development of
a subpopulation of the striatonigral projection neurons. Accord-
ingly, in addition to reduced levels of Gad65, functionally asso-
ciated with striatonigral projection neurons (Laprade and
Figure 4. Molecular abnormalities in theMeis1/ LGE at E13.5.A–E, ISHwas performed
with several genemarkers (as indicated on left side of panels) on coronal sections ofWT (A,B, C,
D, and E) and Meis1/ (A, B, C, D, and E) embryos. The anterior region of the LGE is
shown. Scale bar: A, 500m.
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Soghomonian, 1997), we also observed in Rarb/mice a signif-
icant reduction of Drd1 and SP, some of the key markers specif-
ically enriched in these neurons (Lobo et al., 2006). Such deficits
were evident at E16.5 and E18.5, although their severity was
stronger at E16.5. At this stage we also observed a reduced expres-
sion ofGad67. Recovery ofGad67 expression at E18.5 could sug-
gest delayed neurogenesis of some, but not all, GABAergic
neurons. Importantly, compromised neurogenesis observed at
E13 did not affect development of striatopallidal projection neu-
rons as expression ofDrd2, Penk, or Adora2awere not affected at
E16.5 and E18.5. In agreement with our observations at prenatal
stages, we found significantly lower number of Drd1-positive
neurons, but not of Drd2-positive neurons, in Rarb/ striatum
at birth.Whereas RAR control of development ofDrd1-positive
neurons may explain reduced expression of Drd1 in compound
Rarb;Rxrg-null mutants (Krezel et al., 1998), the reduced expres-
sion ofDrd2 also reported in these animalsmay involve postnatal
functions of RAR, which remain to be investigated.
Since we did not observe increased apoptotic cell death at any
of the analyzed stages, we investigated whether abnormal prolif-
eration and/or neurogenesis could underlie deficits in striatoni-
gral projection neurons in Rarb/ mice. BrdU pulse-chase
analyses revealed a significant decrease in neurogenesis in
Rarb/ LGE at E13, shown previously to affect late-born strio-
somal neurons (Liao et al., 2008). Although such deficit could
affect development of different cell types in the striatum, we fo-
cused our analyses on striatonigral and striatopalldial projection
neurons. Importantly, we show now that deficits in proliferation
are associated with compromised development of striatonigral
neurons, because the number of BrdU-positive cells expressing
Drd1was significantly reduced in the striatumofRarb/mice at
P0, whereas Drd2-expressing BrdU-positive cells were not af-
fected. Reduced expression of prodynorphin, a marker of stria-
tonigral striosomal neurons, and spared expression of Ebf1 and
Chrm4, respective markers of developing and mature striatoni-
gral matrix neurons, suggest that deficits in Drd1 neurons are
restricted to striosomal compartments. Several lines of evidence
suggest that reduced proliferation observed in the Rarb/ LGE
result frompremature differentiation of neural progenitors in the
VZ and SVZ regions. Deficits in neurogenesis at E13.5 illustrated
by reduced expression of Ascl1 (Mash1), a marker of neural pro-
genitors and a determinant of GABAergic neurons in the stria-
tum (Casarosa et al., 1999; Yun et al., 2002), was associated with
concomitant increase in expression of Meis1, which we consid-
ered as a marker of postmitotic neurons due to its expression in
the MZ of the developing striatum and throughout the adult
striatum, which harbor postmitotic neurons. Furthermore,
Meis1 was expressed ectopically in the VZ of the Rarb/ LGE,
where it was found essentially in cells not expressing Ascl1, sug-
gesting their premature differentiation. The relevance of in-
creased activity of Meis1 was supported by enhanced expression
of Dlk1, a direct transcriptional target of Meis1 (Argiropoulos et
al., 2008), which is known as positive regulator of neurogenesis
and terminal differentiation by induction of cell-cycle exit (Sur-
macz et al., 2012).We also found ectopic or enhanced expression
of Isl1 protein in the VZ and SVZ regions. Although signaling
through this transcription factor could promote differentiation
of striatonigral projection neurons, as evidenced by previous re-
ports (Ehrman et al., 2013; Lu et al., 2014), in Rarb/ mice its
ectopic expression in the VZ was found only occasionally in few
isolated cells. Also, enhanced immunofluorescent labeling of Isl1
did not reflect increased expression of Isl1 at the mRNA level,
suggesting the possibility of either post-transcriptional control or
relatively subtle or local changes in Isl1 expression. Also, we did
not observe any mis-specification of Drd1 to Drd2 neurons,
which could be expected in case of overexpression of Isl1 as pre-
viously suggested (Lu et al., 2014). We observed a slight decrease
in expression ofCtip2, a transcription factor important for devel-
opment of striatonigral projection neurons and cellular architec-
ture of the striatum (Arlotta et al., 2008). Functional relevance
and critical contribution of such deficit to abnormal striatal de-
velopment in Rarb/mice is unlikely because we failed to iden-
tify enhanced expression of Secretagogin, Fidgetin, Neurotensin,
or Basonuclin 2 at E18.5, the key molecular hallmarks of abol-
ished Ctip2 expression in neonatal striatum (Arlotta et al., 2008).
It was striking that ablation of RAR, predominantly ex-
pressed in the MZ and weakly in the SVZ (Liao et al., 2003; M.
Rataj and W. Krezel, unpublished observations), affects gene ex-
pression and cell proliferation in a neighboring region (the VZ)
that does not express this receptor. We hypothesized that RAR
triggers noncell-autonomous events by regulating the produc-
tion of extrinsic, diffusible signals, such as RA, or FGFs known for
their regulation of proliferation anddifferentiation of neural pro-
genitors (Chatzi et al., 2011; Guillemot and Zimmer, 2011). We
did not observe any signs of altered bioavailability of RA, as ex-
pression of Raldh3, the only Raldh gene expressed in the devel-
oping LGE, was not affected inRarb/mutants. Also we did not
observe any adaptive changes in expression of Rar, known to be
expressed in the VZ of the LGE (Rar was not detected inWT or
Rarb/ LGE). On the other hand, several lines of evidence sug-
gest that reduced expression of Fgf3, which we observed in the
SVZ region, underlies neurogenesis deficits in the Rarb/ LGE.
Reduced expression of Fgf3 could be of transcriptional origin, as
Fgf3 is a direct transcriptional target of retinoid receptors (Mu-
Figure 5. Schematic model of morphogenic gradients controlling striatal development
and involved in abnormal neurogenesis in Rarb/ mice. Top, Developing LGE is repre-
sented in blue. A gradient of RA activity, generated through combined ligand (Raldh3-
dependent) and receptor (RAR and RAR in SVZ, RAR in MZ) distributions, is
presumably highest in the SVZ. By activating Fgf3 expression, this would allow FGF sig-
naling to be transduced by FGF receptors (FGFR) mainly present in the VZ. Bottom, Neu-
rogenesis in WTmice (black arrows) involves progressive neural specification of stem cells
(circle) and cell divisions of neural progenitors (crossed circles). In Rarb/ mice, a
subpopulation of progenitor cells prematurely expresses Meis1 in the VZ and SVZ regions,
leading to premature differentiation of striatonigral neurons and thus impoverishment of
the pool of striatonigral progenitors that normally undergo differentiation through a
Foxp1-dependent and Ikzf1-dependent pathway.
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rakami et al., 1993; Frenz et al., 2010). While FGF3 and FGF8 act
redundantly for specification of the ventral telencephalon at early
stages of embryogenesis (Theil et al., 2008), at E13.5 FGF3 is the
main FGF available in the proliferative region (VZ and SVZ) of
the LGE, no expression being detected in this region for FGF1,
FGF2, FGF4, FGF5, and FGF8. FGF3 activity is likely restricted to
theVZby the presence of FGF receptors, in particular FGFR1 and
FGFR2, which were demonstrated to play critical roles in devel-
opment of the LGE since their genetic ablation led to the absence
of ventral telencephalic structures (Gutin et al., 2006). In the
present study, the deficit in neurogenesis and enhanced differen-
tiation, highlighted, respectively, by the reduced fraction of
Ascl1-expressing cells and increased number of Meis1-positive
cells, were reproduced in primary cell cultures from E13.5
Rarb/ LGE, and these changes could be normalized by adding
exogenous FGF to the culture medium. Analyses of Ascl1 and
Meis1 expression in cell pairs suggest that ablation of RAR leads
to increased number of symmetric differentiating divisions iden-
tified by expression ofMeis1 in both daughter cells at the expense
of symmetric neurogenic progenitor (Ascl1/Ascl1) cell divi-
sions. FGF treatment essentially normalized this abnormal phe-
notype (with the exception of a partial decrease of symmetric
differentiating divisions) in Rarb/ LGE, but also enhanced the
number of asymmetric divisions in WT but not Rarb/ cul-
tures, suggesting a critical role of compromised FGF signaling in
deficient neurogenesis in Rarb/ LGE.
Our data point to the involvement of Meis1 as one of the
determinants of differentiation during striatal development. This
possibility is further supported by our observation of molecular
abnormalities in the LGEofMeis1/ embryos at E13.5.Whether
these abnormalities would eventually affect differentiation of
striatonigral projection neurons cannot be assessed, asMeis1/
embryos do not survive beyond E14.5 (Azcoitia et al., 2005).
Nevertheless, our findings suggest a potential novel mechanism
in control of striatonigral neuron differentiation, in addition to
pathways involving Isl1 or Ctip2, the key factors reported to play
such a role so far (Arlotta et al., 2008; Ehrman et al., 2013; Lu et
al., 2014). Such role of Meis1 in brain development may be par-
ticularly relevant for the etiology of the restless leg syndrome, for
which the MEIS1 locus was recently identified through genome-
wide association studies and functional analyses (Spieler et al.,
2014).
From the present findings, we propose a model of LGE devel-
opment based on gradients of FGF and RA signaling (Fig. 5).
These gradients are imposed not only by diffusion of FGF3 and
RA from the SVZ, themain source of both ligands in the LGE, but
also by differential distributions of the respective FGF and RA
receptors. Thus, FGF3 diffusing from the SVZ will act mostly in
the VZ, where FGF receptors are expressed, and therefore will
control proliferation of neural progenitor cells, but will also pre-
vent them from terminal differentiation according to a ventrolat-
eral gradient. Cells migrating through the SVZ are exposed to the
RA signal produced in the SVZ through Raldh3-mediated syn-
thesis, and perceived by two RARs: RAR, expressed in the SVZ
region, and RAR, found in the SVZ and the only RAR present in
the MZ during LGE development. Such exposure to RA in the
absence of FGF signal is critical for induction of terminal neuro-
nal differentiation. Molecular changes during the developmental
transition from proliferating neural progenitors to postmitotic
cells is marked by expression of several transcription factors, in-
cluding Ikzf1, Foxp1, or Meis1, out of which the first two were
reported to control differentiation ofMSNs (Tamura et al., 2004;
Martín-Iba´n˜ez et al., 2010), whereas the function ofMeis1 in this
process remains unknown. Our data suggest that Meis1 expres-
sion at the entry of a cell into the MZ may be a determinant of
terminal differentiation for a subpopulation of striatonigral neu-
rons. FGF signaling might orchestrate this process by preventing
Meis1 expression in VZ region. In favor of such negative control
are our data from Rarb/ LGE cell cultures. In Rarb/mutant
mice, reduced FGF signaling leads to ectopic expression ofMeis1
in VZ cells of the LGE and premature differentiation of a subpop-
ulation ofGad65 (Drd1) striatonigral neurons, in turn reduc-
ing the pool of progenitor cells that should normally undergo
Foxp1-dependent events contributing to differentiation of this
pool of projection neurons. Our data from LGE cultures further
support this hypothesis as only in WT conditions did FGF de-
crease the number of Foxp1-positive cells, suggesting a reduction
of differentiation,whereas inRarb/ cultures the pool of Foxp1-
positive cells was reduced on expense ofMeis1-positive cells, and
not affected by FGF treatment. These data suggest that Foxp1 and
Meis1 signaling identify two parallel and mutually exclusive
pathways of differentiation, both sensitive to FGF signaling.
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